Related references
Note: Only part of the references are listed.Executive Summary Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Gordon H. Guyatt et al.
CHEST (2012)
ESC Guidelines on the management of cardiovascular diseases during pregnancy
Vera Regitz-Zagrosek et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
Dabigatran Etexilate The First Oral Anticoagulant Available in the United States Since Warfarin
Arlene Tran et al.
CARDIOLOGY IN REVIEW (2011)
Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: no easy option
Claire McLintock
THROMBOSIS RESEARCH (2011)
The effect of warfarin dosage on maternal and fetal outcomes in pregnant women with prosthetic heart valves
P. Soma-Pillay et al.
OBSTETRIC MEDICINE (2011)
ESC Guidelines on the management of cardiovascular diseases during pregnancy The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)
Vera Regitz-Zagrosek et al.
EUROPEAN HEART JOURNAL (2011)
Fetotoxicity of warfarin anticoagulation
Sumit Mehndiratta et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2010)
Predictors of pregnancy complications in women with congenital heart disease
Willem Drenthen et al.
EUROPEAN HEART JOURNAL (2010)
Fluctuations in anti-factor Xa levels with therapeutic enoxaparin anticoagulation in pregnancy
E. Friedrich et al.
JOURNAL OF PERINATOLOGY (2010)
Choice of Prosthetic Heart Valve in Adults An Update
Shahbudin H. Rahimtoola
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Fondaparinux as an alternative anticoagulant therapy during pregnancy
H. M. Knol et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Ross principle and concept of a living valve
Salvatore Lentini
LANCET (2010)
Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial
Ismail El-Hamamsy et al.
LANCET (2010)
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery.
Martin B. Leon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition)
Terese T. Horlocker et al.
REGIONAL ANESTHESIA AND PAIN MEDICINE (2010)
An analysis of clinical outcomes of 91 pregnancies in 83 women treated with danaparoid (Orgaran®)
H. N. Magnani
THROMBOSIS RESEARCH (2010)
Use of Low Molecular Weight Heparin in Pregnant Women With Mechanical Heart Valves
Yoav Yinon et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin
C. McLintock et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2009)
Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: a single-center experience
John Quinn et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome
Spiros Dendrinos et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2009)
Management of pregnant women with mechanical heart valve prosthesis: Thromboprophylaxis with Low molecular weight heparin
Ulrich Abildgaard et al.
THROMBOSIS RESEARCH (2009)
Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy
Shannon M. Bates et al.
CHEST (2008)
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
Robert O. Bonow et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Heparin-induced thrombocytopenia - therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes
K. Krauel et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Preterm birth 1 - Epidemiology and causes of preterm birth
Robert L. Goldenberg et al.
LANCET (2008)
Lepirudin for treatment of acute thrombosis during pregnancy
Moncenya L. Chapman et al.
OBSTETRICS AND GYNECOLOGY (2008)
Pregnancy Outcome in Women with Antiphospholipid Antibodies: Report on a Retrospective Study
Lothar Heilmann et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2008)
New oral Xa and IIa inhibitors: updates on clinical trial results
Sylvia Haas
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2008)
The use of low-molecular-weight heparins in pregnancy - how safe are they?
Philippe Deruelle et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2007)
The Ross operation: a Trojan horse?
Loes M. A. Klieverik et al.
EUROPEAN HEART JOURNAL (2007)
Risks and pregnancy outcome in women with prosthetic mechanical heart valve replacement
Kazuya Kawamata et al.
CIRCULATION JOURNAL (2007)
Low molecular weight heparin treatment in pregnant women with a mechanical heart valve prosthesis
Jae Hoon Lee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2007)
Fondaparinux as anticoagulant in a pregnant woman with heparin allergy
Ajith Wijesiriwardana et al.
BLOOD COAGULATION & FIBRINOLYSIS (2006)
Drug therapy -: Direct thrombin inhibitors
M Di Nisio et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Valvular heart disease and pregnancy - Part II: Prosthetic valves
U Elkayam et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy
IA Greer et al.
BLOOD (2005)
Comparative pharmacokinetics of vitamin K antagonists - Warfarin, phenprocoumon and acenocoumarol
M Ufer
CLINICAL PHARMACOKINETICS (2005)
Pregnancy-induced changes in pharmacokinetics - A mechanistic-based approach
GD Anderson
CLINICAL PHARMACOKINETICS (2005)
Pregnancy outcome in women with prosthetic heart valves
AH Nassar et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
A prospective triat that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levets of anticoagulation
LA Barbour et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
Prosthetic heart valves and pregnancy
L Hung et al.
CIRCULATION (2003)
Report of the Dutch experience with the Ross procedure in 343 patients
JJM Takkenberg et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2002)
Homograft aortic root replacement during pregnancy
K Gopal et al.
ANNALS OF THORACIC SURGERY (2002)
Risk of warfarin during pregnancy with mechanical valve prostheses
M Cotrufo et al.
OBSTETRICS AND GYNECOLOGY (2002)
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
KA Bauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range
J Hirsh et al.
CHEST (2001)
Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves
L Sadler et al.
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2000)
Anticoagulation of pregnant women with mechanical heart valves -: A systematic review of the literature
WS Chan et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
